Allogeneic Stem Cell Transplant Feasible for Leukemia in Elderly Patients

TUESDAY, Feb. 21, 2023 -- In elderly adults aged 60 years and older with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS), allogeneic hematopoietic stem cell transplant (HSCT) can be performed with acceptable overall survival and...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news